KMT2C and hepatocellular carcinoma: In addition to its role in hepatocellular cancers, KMT2C regulates bile acid (BA) homeostasis by modulating the expression of Farnesoid X Receptor (FXRs) and p53-dependent small heterodimeric chaperone receptors (SHPs) (70).